TDP-43 is intercellularly transmitted across axon terminals

Journal of Cell Biology

Volumn 211, Issue 4, 2015, Pages 897-911

  Feiler, Marisa S ^a   Strobel, Benjamin ^b   Freischmidt, Axel ^a   Helferich, Anika M ^a   Kappel, Julia ^a   Brewer, Bryson M ^c   Li, Deyu ^c   Thal, Dietmar R ^a   Walther, Paul ^a   Ludolph, Albert C ^a   Danzer, Karin M ^a   Weishaupt, Jochen H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAR DNA BINDING PROTEIN; DNA BINDING PROTEIN; TDP-43 PROTEIN, HUMAN;

AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL GRANULE; CELL STRESS; CONTROLLED STUDY; EMBRYO; EXOSOME; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEMBRANE MICROPARTICLE; MICROFLUIDICS; MOUSE; NERVE CELL CULTURE; NERVE ENDING; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; SYNAPTIC TRANSMISSION; TARGET CELL; TDP 43 PROTEINOPATHY; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; C57BL MOUSE; HEK293 CELL LINE; METABOLISM; NERVE CELL; PROTEIN MULTIMERIZATION; SECRETION (PROCESS);

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DNA-BINDING PROTEINS; EXOSOMES; HEK293 CELLS; HUMANS; MICE, INBRED C57BL; NEURONS; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; SYNAPTIC TRANSMISSION;

EID: 84970952328     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201504057     Document Type: Article

References (48)

1. Braak, H., and E. Braak. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:239-259. http://dx.doi.org/10.1007/BF00308809
2. Braak, H., K. Del Tredici, U. Rüb, R.A. de Vos, E.N. Jansen Steur, and E. Braak. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 24:197-211. http://dx.doi.org/10.1016/S0197-4580(02)00065-9
3. Braak, H., J. Brettschneider, A.C. Ludolph, V.M. Lee, J.Q. Trojanowski, and K. Del Tredici. 2013. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat. Rev. Neurol. 9:708-714. http://dx.doi.org/10.1038/nrneurol.2013.221
4. Brettschneider, J., K. Del Tredici, J.B. Toledo, J.L. Robinson, D.J. Irwin, M. Grossman, E. Suh, V.M. Van Deerlin, E.M. Wood, Y. Baek, et al. 2013. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74:20-38. http://dx.doi.org/10.1002/ana.23937
5. Brettschneider, J., K. Arai, K. Del Tredici, J.B. Toledo, J.L. Robinson, E.B. Lee, S. Kuwabara, K. Shibuya, D.J. Irwin, L. Fang, et al. 2014. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 128:423-437. http://dx.doi.org/10.1007/s00401-014-1299-6
6. Budini, M., E. Buratti, C. Stuani, C. Guarnaccia, V. Romano, L. De Conti, and F.E. Baralle. 2012. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J. Biol. Chem. 287:7512-7525. http://dx.doi.org/10.1074/jbc.M111.288720
7. Charcot, J.M. 1874. Amyotrophies spinales deuteropathiques sclérose latérale amyotrophique & sclérose latérale amyotrophique. Bureaux du Progrès Médical. 2:234-266
8. Chernyshev, V.S., R. Rachamadugu, Y.H. Tseng, D.M. Belnap, Y. Jia, K.J. Branch, A.E. Butterfield, L.F. Pease III, P.S. Bernard, and M. Skliar. 2015. Size and shape characterization of hydrated and desiccated exosomes. Anal. Bioanal. Chem. 407:3285-3301. http://dx.doi.org/10.1007/s00216-015-8535-3
9. Danzer, K.M., S.K. Krebs, M. Wolff, G. Birk, and B. Hengerer. 2009. Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology. J. Neurochem. 111:192-203. http://dx.doi.org/10.1111/j.1471-4159.2009.06324.x
10. Danzer, K.M., W.P. Ruf, P. Putcha, D. Joyner, T. Hashimoto, C. Glabe, B.T. Hyman, and P.J. McLean. 2011. Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FAS EB J. 25:326-336. http://dx.doi.org/10.1096/fj.10-164624
11. Danzer, K.M., L.R. Kranich, W.P. Ruf, O. Cagsal-Getkin, A.R. Winslow, L. Zhu, C.R. Vanderburg, and P.J. McLean. 2012. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 7:42. http://dx.doi.org/10.1186/1750-1326-7-42
12. Dewey, C.M., B. Cenik, C.F. Sephton, D.R. Dries, P. Mayer III, S.K. Good, B.A. Johnson, J. Herz, and G. Yu. 2011. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell. Biol. 31:1098-1108. http://dx.doi.org/10.1128/MCB.01279-10
13. Feneberg, E., P. Steinacker, S. Lehnert, A. Schneider, P. Walther, D.R. Thal, M. Linsenmeier, A.C. Ludolph, and M. Otto. 2014. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph. Lateral Scler. Frontotemporal Degener. 15:351-356. http://dx.doi.org/10.3109/21678421.2014.905606
14. Fiesel, F.C., and P.J. Kahle. 2011. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. FEBS J. 278:3550-3568. http://dx.doi.org/10.1111/j.1742-4658.2011.08258.x
15. Goedert, M., B. Falcon, F. Clavaguera, and M. Tolnay. 2014. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies. Curr. Neurol. Neurosci. Rep. 14:495. http://dx.doi.org/10.1007/s11910-014-0495-z
16. Gowers, W.R. 1886. A Manual of Diseases of the Nervous System. J & A Churchill, London. 992 pp
17. Igaz, L.M., L.K. Kwong, E.B. Lee, A. Chen-Plotkin, E. Swanson, T. Unger, J. Malunda, Y. Xu, M.J. Winton, J.Q. Trojanowski, and V.M. Lee. 2011. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Invest. 121:726-738. http://dx.doi.org/10.1172/JCI44867
18. Johnson, B.S., D. Snead, J.J. Lee, J.M. McCaffery, J. Shorter, and A.D. Gitler. 2009. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284:20329-20339. http://dx.doi.org/10.1074/jbc.M109.010264
19. Kanouchi, T., T. Ohkubo, and T. Yokota. 2012. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J. Neurol. Neurosurg. Psychiatry. 83:739-745. http://dx.doi.org/10.1136/jnnp-2011-301826
20. Kawahara, Y., and A. Mieda-Sato. 2012. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA. 109:3347-3352. http://dx.doi.org/10.1073/pnas.1112427109
21. Luk, K.C., C. Song, P. O'Brien, A. Stieber, J.R. Branch, K.R. Brunden, J.Q. Trojanowski, and V.M. Lee. 2009. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA. 106:20051-20056. http://dx.doi.org/10.1073/pnas.0908005106
22. Luk, K.C., V.M. Kehm, B. Zhang, P. O'Brien, J.Q. Trojanowski, and V.M. Lee. 2012. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp. Med. 209:975-986. http://dx.doi.org/10.1084/jem.20112457
23. Maniecka, Z., and M. Polymenidou. 2015. From nucleation to widespread propagation: A prion-like concept for ALS. Virus Res. 207:94-105. http://dx.doi.org/10.1016/j.virusres.2014.12.032
24. Masuda-Suzukake, M., T. Nonaka, M. Hosokawa, T. Oikawa, T. Arai, H. Akiyama, D.M. Mann, and M. Hasegawa. 2013. Prion-like spreading of pathological α-synuclein in brain. Brain. 136:1128-1138. http://dx.doi.org/10.1093/brain/awt037
25. Meyer-Luehmann, M., J. Coomaraswamy, T. Bolmont, S. Kaeser, C. Schaefer, E. Kilger, A. Neuenschwander, D. Abramowski, P. Frey, A.L. Jaton, et al. 2006. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science. 313:1781-1784. http://dx.doi.org/10.1126/science.1131864
26. Neumann, M., D.M. Sampathu, L.K. Kwong, A.C. Truax, M.C. Micsenyi, T.T. Chou, J. Bruce, T. Schuck, M. Grossman, C.M. Clark, et al. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 314:130-133. http://dx.doi.org/10.1126/science.1134108
27. Neumann, M., L.K. Kwong, E.B. Lee, E. Kremmer, A. Flatley, Y. Xu, M.S. Forman, D. Troost, H.A. Kretzschmar, J.Q. Trojanowski, and V.M. Lee. 2009. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117:137-149. http://dx.doi.org/10.1007/s00401-008-0477-9
28. Nishihira, Y., C.F. Tan, Y. Hoshi, K. Iwanaga, M. Yamada, I. Kawachi, M. Tsujihata, I. Hozumi, T. Morita, O. Onodera, et al. 2009. Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol. 117:45-53. http://dx.doi.org/10.1007/s00401-008-0443-6
29. Nonaka, T., M. Masuda-Suzukake, T. Arai, Y. Hasegawa, H. Akatsu, T. Obi, M. Yoshida, S. Murayama, D.M. Mann, H. Akiyama, and M. Hasegawa. 2013. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Reports. 4:124-134. http://dx.doi.org/10.1016/j.celrep.2013.06.007
30. Outeiro, T.F., P. Putcha, J.E. Tetzlaff, R. Spoelgen, M. Koker, F. Carvalho, B.T. Hyman, and P.J. McLean2008 Formation of toxic oligomeric α-synuclein species in living cells. PLoS One. 2:e1867. http://dx.doi.org/10.1371/journal.pone.0001867
31. Pasinelli, P., and R.H. Brown. 2006. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7:710-723. http://dx.doi.org/10.1038/nrn1971
32. Pesiridis, G.S., V.M. Lee, and J.Q. Trojanowski. 2009. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18(R2):R156-R162. http://dx.doi.org/10.1093/hmg/ddp303
33. Polymenidou, M., and D.W. Cleveland. 2011. The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 147:498-508. http://dx.doi.org/10.1016/j.cell.2011.10.011
34. Ravits, J.M., and A.R. La Spada. 2009. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 73:805-811. http://dx.doi.org/10.1212/WNL.0b013e3181b6bbbd
35. Remy, I., and S.W. Michnick. 2006. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat. Methods. 3:977-979. http://dx.doi.org/10.1038/nmeth979
36. Reyes, J.F., T.T. Olsson, J.T. Lamberts, M.J. Devine, T. Kunath, and P. Brundin. 2014. A cell culture model for monitoring α-synuclein cell-to-cell transfer. Neurobiol. Dis. 77:266-275. http://dx.doi.org/10.1016/j.nbd.2014.07.003
37. Sato, H., T. Kato, and S. Arawaka. 2014. Potential of cellular and animal models based on a prion-like propagation of α-synuclein for assessing antiparkinson agents. Mol. Neurobiol
38. Sreedharan, J., I.P. Blair, V.B. Tripathi, X. Hu, C. Vance, B. Rogelj, S. Ackerley, J.C. Durnall, K.L. Williams, E. Buratti, et al. 2008. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 319:1668-1672. http://dx.doi.org/10.1126/science.1154584
39. Strobel, B., F.D. Miller, W. Rist, and T. Lamla. 2015. Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant Adeno-associated virus (AAV) vectors for preclinical applications. Hum. Gene Ther. Methods. 26:147-157. http://dx.doi.org/10.1089/hgtb.2015.051
40. Tannous, B.A., D.E. Kim, J.L. Fernandez, R. Weissleder, and X.O. Breakefield. 2005. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 11:435-443. http://dx.doi.org/10.1016/j.ymthe.2004.10.016
41. Thery, C., S. Amigorena, G. Raposo, and A. Clayton. 2006. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. In Current Protocols in Cell Biology. John Wiley & Sons Inc., New York. 3.22.1-3.22.29. http://dx.doi.org/10.1002/0471143030.cb0322s30
42. Tsai, K.J., C.H. Yang, Y.H. Fang, K.H. Cho, W.L. Chien, W.T. Wang, T.W. Wu, C.P. Lin, W.M. Fu, and C.K. Shen. 2010. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J. Exp. Med. 207:1661-1673. http://dx.doi.org/10.1084/jem.20092164
43. Wilkat, M., E. Herdoiza, V. Forsbach-Birk, P. Walther, and A. Essig. 2014. Electron tomography and cryo-SEM characterization reveals novel ultrastructural features of host-parasite interaction during Chlamydia abortus infection. Histochem. Cell Biol. 142:171-184. http://dx.doi.org/10.1007/s00418-014-1189-y
44. Wils, H., G. Kleinberger, J. Janssens, S. Pereson, G. Joris, I. Cuijt, V. Smits, C. Ceuterick-de Groote, C. Van Broeckhoven, and S. Kumar-Singh. 2010. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 107:3858-3863. http://dx.doi.org/10.1073/pnas.0912417107
45. Xu, Y.F., T.F. Gendron, Y.J. Zhang, W.L. Lin, S. D'Alton, H. Sheng, M.C. Casey, J. Tong, J. Knight, X. Yu, et al. 2010. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 30:10851-10859. http://dx.doi.org/10.1523/JNEUROSCI.1630-10.2010
46. Zhang, Y.J., Y.F. Xu, C. Cook, T.F. Gendron, P. Roettges, C.D. Link, W.L. Lin, J. Tong, M. Castanedes-Casey, P. Ash, et al. 2009. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 106:7607-7612. http://dx.doi.org/10.1073/pnas.0900688106
47. Zhou, J., E.D. Gennatas, J.H. Kramer, B.L. Miller, and W.W. Seeley. 2012. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 73:1216-1227. http://dx.doi.org/10.1016/j.neuron.2012.03.004
48. Zhu, L., M. Xu, M. Yang, Y. Yang, Y. Li, J. Deng, L. Ruan, J. Liu, S. Du, X. Liu, et al. 2014. An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution. Hum. Mol. Genet. 23:6863-6877. http://dx.doi.org/10.1093/hmg/ddu409